Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
Adcentrx Therapeutics has raised $51.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Adcentrx Therapeutics's investors include F-Prime Capital, Partners Investment, Eight Roads Ventures, C-Bridge Capital, Quan Capital.
Adcentrx Therapeutics is headquartered in San Diego, United States.
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
Adcentrx Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adcentrx Therapeutics — Funding & Investors." VCBacked, April 24, 2023, https://www.vcbacked.co/company/adcentrx-therapeutics. Accessed August 1, 2026.
VCBacked. (2023). Adcentrx Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/adcentrx-therapeutics
{{cite web |title=Adcentrx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/adcentrx-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated